Journal article icon

Journal article

Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial.

Abstract:

WHO 2013 guidelines recommend universal treatment for HIV-infected children younger than 5 years. No paediatric trials have compared nucleoside reverse-transcriptase inhibitors (NRTIs) in first-line antiretroviral therapy (ART) in Africa, where most HIV-infected children live. We aimed to compare stavudine, zidovudine, or abacavir as dual or triple fixed-dose-combination paediatric tablets with lamivudine and nevirapine or efavirenz.In this open-label, parallel-group, randomised trial (CHAPAS...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Authors


More from this funder
Name:
European Developing Countries Clinical Trials Partnership
Grant:
IP.2007.33011.006
More from this funder
Name:
Ministerio de Sanidady Consumo Spain
More from this funder
Name:
Department for International Development
Publisher:
Elsevier
Journal:
Lancet. Infectious diseases More from this journal
Volume:
16
Issue:
2
Pages:
169-179
Publication date:
2016-02-01
DOI:
EISSN:
1474-4457
ISSN:
1473-3099
Language:
English
Keywords:
Pubs id:
pubs:588407
UUID:
uuid:6812cf0e-1a17-4f31-8427-186c0e240f35
Local pid:
pubs:588407
Source identifiers:
588407
Deposit date:
2016-02-22

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP